Biotech for less than cash value | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotech for less than cash value

An SI Board Since April 2002

Posts	SubjectMarks	Bans
684	125	0

Emcee: RWReeves	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
84	Thanks for making this list. This looks dangerously close to my portfolio <vb	RWReeves	-	7/9/2002
83	Ron: VPHM is not working on a RSV vaccine. Their first candidate, in phase I h	scaram(o)uche	-	7/8/2002
82	<Toni Clarke's article is, IMO, filled with dogma and fluff crap> Rig	Elmer	-	7/8/2002
81	>> A company with a significant burn rate will simply run out of cash <	scaram(o)uche	-	7/8/2002
80	<i>"Genetics and genomics will play a major role in the future of the	AurumRabosa	-	7/8/2002
79	List of bio's below cash: Co. MV Cash Vphm $33.4 $213.9	rkrw	-	7/8/2002
78	Ron Yes the longer the survival index the beter the bargaining position stefaa	dalroi	-	7/8/2002
77	"Disillusion with genetic advances depresses biotechs" <i>A cou	249443	-	7/8/2002
76	Just scratching the surface on this look at BFLTCV stocks. Some of these I would	AurumRabosa	-	7/8/2002
75	ron acla is special case yahoo lists its cash indeed around 70m but when lookin	dalroi	-	7/8/2002
74	Yes, if they spend all their money and don't develop a medicine, they will b	scaram(o)uche	-	7/8/2002
73	VPHN Market Capitalization $28.9M Total Cash (mrq) $213.9M Looks interesting,	bits	-	7/7/2002
72	very considerate of you. thanks for helping! I own parts of five of those. Ri	scaram(o)uche	-	7/7/2002
71	Here's a summary list I made while reading the whole thread: finance.yahoo.	AurumRabosa	-	7/7/2002
70	The BTK was down 30.27% for the Quarter ending 3/28/02 (see biobiznet.com). Also	blackmerlin	-	7/6/2002
69	CRGN & VICL mentioned on this thread were recommended on the tube last night	AuBug	-	7/6/2002
68	This is some data I posted on another biotech thread....pretty sobering to see t	Arthur Radley	-	7/5/2002
67	Just wishful thinking. I don't like them. I don't like companies that	scaram(o)uche	-	7/5/2002
66	Richard, re cra. This one mentioned in Barrons article on 5/27. Of those ment	Allen Furlan	-	7/5/2002
65	VPHM.... driving me nuts. The more I consider it, the more likely it seems,	scaram(o)uche	-	7/5/2002
64	Any chance of attaching either a portfolio, or a watchlist, to the thread ? nig	nigel bates	-	7/5/2002
63	Hi Mike, the sector sure marches to the beat of a different drum. Trouble has	RWReeves	-	7/5/2002
62	<i>IMGN...certainly oversold</i> Current cap now $85m. Interesting	nigel bates	-	7/4/2002
61	Thanks :-) ...This is wringing in my head lately, my kid loves it, heheh. <	Mike McFarland	-	7/4/2002
60	Mike McFarland, OT: I've scanned through every one of the biotech companies	Paul Senior	-	7/4/2002

Go to reply# or date (mm/dd/yy):